ipharma tirzepatide south africa Tirzepsema 34mg Pre-Filled Pen IPH (RXME Hybrid) NICE recommends Lilly's tirzepatide for

Clinical studies show that weight loss typically continues for 6-12 months before plateauing, and discontinuing the medication often leads to weight regain

Patients often report feeling less irritable or anxious, and even finding relief from symptoms of depression linked to their deficiency

Patients should report any visual changes, severe abdominal pain, persistent nausea or vomiting, signs of pancreatitis, or symptoms of thyroid tumors (neck mass, dysphagia, dyspnea) to their healthcare provider immediately

The availability of an oral formulation may improve accessibility and convenience for individuals who are uncomfortable with injectable medications